14th Annual AKI Symposium
This symposium will promote the clinical knowledge related to diagnosis and personalized treatment of acute kidney injury (AKI). It will help to improve the care of critically ill patients who develop or are at risk for AKI. It will also promote communication and collaboration among experts and specialists treating and researching acute kidney injury. The understanding of AKI and the effective strategies for developing, implementing, and performing protocols for managing the condition will be enhanced. The symposium is targeted for doctors, fellows, researchers, and professionals in the medical and research fields of critical care medicine, transplantation, nephrology, and the renal-electrolyte division. The symposium also serves as a platform to spread kidney awareness and to educate and share resources with patients and the community.
Target Audience
The symposium is targeted for doctors, fellows, researchers, and professionals in the medical and research fields of critical care medicine, transplantation, nephrology, and the renal-electrolyte division.
Additional Information
Attachment | Size |
---|---|
![]() | 2.24 MB |
![]() | 384.66 KB |
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
1. Dr. Aravind Cherukuri is a consultant and on the advisory board for Verici diagnostics and Biohope Pharmaceuticals.
2. Dr. Samit Ghosh has grant/research support from Pfizer, Inc.
3. Ms. Annabelle Lint was a paid intern for Amgen during the summer of 2024. This relationship has ended.
4. Dr. Dennis Moledina is a consultant for Biohaven, Inc. and is a stockholder (**privately held) for Predict AIN, LLC.
5. Dr. Raghavan Murugan was previously a paid consultant for Baxter Inc. This relationship has ended.
6. Dr. Ashita Tolwani is a consultant for Baxter, Inc.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.50 Attendance
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by e-mailing Maria Delesio at [email protected].
Cancellation requests can be made to:
Maria Delesio
Admin Coordinator, Research
Renal-Electrolyte Division
University of Pittsburgh
412-383-9753
[email protected]